Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab

Clinical trial NCT06272695 · COMPLETED

Trial details

NCT number: NCT06272695
Sponsor: REMD Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2024-02-15
Primary completion: 2025-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.